As of Feb 20, 2025, Fresenius Medical Care AG & Co. KGaA's discount rate is 4.78%. This rate is determined based on the weighted average cost of capital (WACC) and the cost of equity, factoring in Fresenius Medical Care AG & Co. KGaA's capital structure and risk profile.
Fresenius Medical Care AG & Co. KGaA's WACC as of Feb 20, 2025, is 4.78%. This value is calculated by blending the cost of debt and cost of equity, reflecting the company’s overall cost of financing its operations.
Fresenius Medical Care AG & Co. KGaA's cost of equity is 8.4%, as of Feb 20, 2025. This is the return that shareholders expect based on the stock's risk level and market conditions, used to calculate the discount rate for valuing future cash flows.